$attachment$

+6 more

Explain each and every line with reasons with details like you are giving a lecture. Also explain complicated terms that are written here. Explain as explaining to non medico

Reading File

This is a rich, multi-page cardiology textbook spread covering pages 318-327. Let me read all images carefully and give you a thorough lecture-style explanation. This will be a long, detailed response - let me cover every page systematically.

CARDIOVASCULAR - Full Lecture Explanation (Pages 318-327)

PAGE 318 - SYNCOPE, INFECTIVE ENDOCARDITIS, NONBACTERIAL THROMBOTIC ENDOCARDITIS

SYNCOPE

"Syncope" simply means a sudden, temporary loss of consciousness - what most people call "fainting." It happens because the brain briefly doesn't get enough blood (and therefore enough oxygen).

Types of Syncope:

Reflex (most common) - Also called "vasovagal syncope."

Think of this as your nervous system overreacting. When you feel pain, fear, heat, or emotional stress, your heart rate slows down and blood vessels widen too much - blood pools in your legs and your brain gets less blood. You faint.
Classic example: seeing blood and fainting, or standing in a hot crowd.

Orthostatic - "Ortho" = upright, "static" = standing.

When you stand up quickly, blood rushes to your legs due to gravity. Normally, your body compensates by squeezing blood vessels and speeding your heart up. But in some people this compensation fails - blood pressure drops suddenly on standing. This is called orthostatic hypotension (drop in BP when standing).
Defined as: systolic BP drops by 20 mmHg OR diastolic BP drops by 10 mmHg upon standing.
Causes: dehydration, medications (antihypertensives), diabetes damaging nerves (autonomic dysfunction), wearing tight collars (carotid sinus hypersensitivity).

Cardiac - The heart itself stops beating properly for a moment.

Causes include arrhythmias (abnormal heart rhythms) and structural problems like aortic stenosis (the main heart valve becoming stiff and narrow).

INFECTIVE ENDOCARDITIS

"Endocarditis" = inflammation of the inner lining of the heart. "Infective" = caused by a microorganism (bacteria, fungi).

The endocardium is the smooth inner surface of the heart - think of it like the lining of a bag. The heart valves are part of this lining. When bacteria get into the bloodstream, they can stick to the heart valves (especially damaged or abnormal ones) and form messy, destructive clumps called "vegetations" (they look like tiny cauliflower growths on the valves).

Which valves are affected?

Mitral valve (most common) - the valve between the left upper and lower heart chambers.
Then aortic > tricuspid > pulmonary (in order of frequency).

How do bacteria get into the blood?

IV (intravenous) drug use - injecting drugs with dirty needles sends bacteria directly into veins. These bacteria love the tricuspid valve (right heart valve) because blood from veins goes there first.
Dental procedures - tooth-cleaning or extractions can push bacteria from your mouth into your blood.
GI/GU (gut or urinary tract) procedures.
Having prosthetic (artificial) heart valves - bacteria love artificial surfaces.

Common associations:

Prosthetic valves: S. epidermidis (a skin bacteria)
Colon cancer: S. gallolyticus (formerly known as S. bovis)
IV drug users: S. aureus (the notorious "staph" bug)

HACEK organisms - This is a group of bacteria (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella) that normally live in the mouth/throat but can cause endocarditis. They are gram-negative.

Culture-negative endocarditis (meaning blood cultures don't grow bacteria) - caused by:

Coxiella burnetii (causes Q fever)
Bartonella
These organisms are difficult to grow in standard lab cultures.

Acute vs. Subacute Endocarditis:

Acute - caused by highly virulent (aggressive) bacteria, classically S. aureus (staph).

Attacks normal, healthy valves.
Rapid, destructive onset - the patient gets very sick very quickly.
Large, destructive vegetations form.

Subacute - caused by less aggressive bacteria, classically Streptococcus viridans.

Attacks previously abnormal or diseased valves (e.g., congenitally malformed valves).
Slower, more gradual onset.
Smaller vegetations. Patient feels unwell for weeks before diagnosis.
Sequela of dental procedures (these bacteria live in the mouth).

Vascular Phenomena (signs you can see/feel on the patient's body):

When vegetations form, tiny pieces can break off and travel through the bloodstream - this is called "septic embolism." These fragments cause:

Petechiae - tiny pin-point red dots on the skin from small bleeding
Splinter hemorrhages - thin red lines under fingernails (like a splinter - see the image in the textbook showing fingers with red lines under nails)
Janeway lesions - flat, painless red spots on the palms or soles. Caused by septic emboli.
Roth spots - oval white spots on the retina (back of your eye) surrounded by bleeding
Osler nodes - PAINFUL raised bumps on the fingertips or toes. (Remember: Osler = Ouch!)

Immunologic phenomena - The immune system reacts to the bacteria, causing:

Glomerulonephritis - kidney inflammation (from immune complexes depositing)
These patients can have blood in urine (hematuria)

Diagnosis: Requires echocardiography (ultrasound of the heart) and blood cultures. "Duke criteria" are used clinically.

Endothelial injury → formation of vegetations (clumps of platelets, fibrin, and microbes on heart valves).

Note: Systemic embolism - if vegetations go to the pulmonary circulation (lungs), it requires multiple blood cultures + echocardiography to confirm.

NONBACTERIAL THROMBOTIC ENDOCARDITIS (NBTE)

Also called "marantic endocarditis."

"Non-bacterial" = no bugs involved. "Thrombotic" = blood clots forming on the valve.
Vegetations are sterile (no bacteria) - they are made only of platelets and fibrin (clotting proteins). This is why they are called "noninfective."
Found on the mitral or aortic valve.
These vegetations are flat, small, and sit along the edge of the valve leaflets.
They don't usually destroy the valve, but they can break off and cause strokes or other emboli.
Usually the patient has no symptoms until an embolus causes a problem.

When does this happen?

In patients with hypercoagulable states (conditions where blood clots too easily) - especially in:
- Advanced malignancy (cancer) - particularly adenocarcinoma (e.g., pancreatic, lung cancer)
- SLE (Systemic Lupus Erythematosus) - an autoimmune disease. In this context, NBTE in lupus is called "Libman-Sacks endocarditis."

Sacks endocarditis = a special form of NBTE in lupus, where vegetations form on BOTH sides of the mitral valve leaflets (this is unique and helps distinguish it).

PAGE 319 - RHEUMATIC FEVER, SYPHILITIC HEART DISEASE, ACUTE PERICARDITIS, CONSTRICTIVE PERICARDITIS

RHEUMATIC FEVER

"Rheumatic fever" is a disease that happens AFTER an untreated throat infection with a specific bacteria called Group A beta-hemolytic Streptococcus (the "strep throat" bacteria). It is NOT the bacteria itself infecting the heart - it is the body's own immune system making a mistake.

Here's the key concept: The strep bacteria has proteins on its surface that look similar to proteins in your heart. So the antibodies your immune system makes to fight the bacteria accidentally attack your own heart. This is called molecular mimicry - the bacteria is "mimicking" (looking like) your own tissue.

Specifically:

The bacteria's M protein cross-reacts with myosin (a protein in heart muscle) and other self-antigens.
Anti-streptolysin O (ASO) titers - these are antibodies measured in blood tests to prove the patient had a recent strep infection.
Anti-DNase B titers - another marker of strep infection.
Treatment: Penicillin (and prophylaxis with penicillin to prevent future strep infections).

What does rheumatic fever do to the heart (Late Sequelae)?

It causes rheumatic heart disease - scarring of heart valves.
Most commonly affects: Mitral > Aortic > Tricuspid > Pulmonary (in that order).
The main damage: high-pressure valve regurgitation (the valve doesn't close properly, blood leaks backward) or stenosis (valve becomes stiff and narrow). Early: regurgitation. Late: stenosis.

Jones Criteria for diagnosis (mnemonic ♥NES):

Joints - migratory polyarthritis (joints hurt in a moving pattern - one knee, then elbow, etc.)
❤ - pancarditis (the whole heart is inflamed - pericardium, myocardium, endocardium)
Nodules - subcutaneous nodules (small lumps under the skin)
Erythema marginatum - a rash with a wavy, irregular margin on the limbs and face (it moves around)
Sydenham chorea - involuntary, irregular movements of the limbs and face. This is a neurological finding from immune attack on the brain.

Histology (what the tissue looks like under a microscope):

Aschoff bodies - the hallmark of rheumatic fever. These are granulomas (collections of immune cells) in the heart tissue. They contain:
- Anitschkow cells - enlarged macrophages with a caterpillar-shaped (owl-eye) nucleus. Diagnostic of rheumatic fever.

SYPHILITIC HEART DISEASE

Syphilis is a sexually transmitted infection caused by the bacteria Treponema pallidum.

Tertiary (3rd stage) syphilis (happening years after the initial infection) can attack the aorta (the main artery leaving the heart):

The bacteria damages the vasa vasorum - these are tiny blood vessels that supply blood to the wall of the aorta itself ("blood vessels of the blood vessel wall").
When these tiny vessels are damaged, the aortic wall becomes weak and can expand like a balloon.
This leads to aneurysm of the ascending aorta (ballooning of the first part of the aorta) and aortic insufficiency (the aortic valve doesn't close properly - blood leaks back into the heart).
The aorta may show calcification of the ascending aorta and aortic root.
Classic appearance: "tree bark" pattern - the damaged inner lining of the aorta looks rough like tree bark.

ACUTE PERICARDITIS

"Pericardium" = the sac surrounding the heart. "Pericarditis" = inflammation of that sac.

Symptoms:

Sharp chest pain
Gets worse when lying flat
Gets better when sitting up and leaning forward (classic!)
Friction rub - you can hear a scratching noise with a stethoscope (like two pieces of sandpaper rubbing together - the inflamed pericardial layers rubbing)
ECG changes: Widespread ST elevation and/or PR depression (changes on the heart electrical tracing)

Causes:

Most common: Viral - coxsackievirus B is the classic cause. Also seen after a heart attack (post-MI pericarditis), rheumatoid arthritis, SLE, renal failure (uremia - urea builds up in blood when kidneys fail, irritating pericardium).
Treatment: NSAIDs (like ibuprofen) and colchicine (anti-inflammatory drug originally used for gout).

Pericardial effusion = fluid builds up in the pericardial sac. This happens with inflammation.

On ECG: shows as diffuse ST elevation.
On chest X-ray: the heart shadow looks big.

CONSTRICTIVE PERICARDITIS

Chronic (long-term) inflammation of the pericardium leads to scarring and hardening - the pericardium becomes stiff like a shell around the heart.

Effect: The heart cannot expand properly to fill with blood → "restricted filling" → low output → the body backs up with fluid.

Signs:

Dyspnea (breathlessness)
Peripheral edema (swollen legs)
Pulsus paradoxus - an exaggerated drop in blood pressure during normal breathing in. Here's why: when you breathe in, the stiff pericardium doesn't let the heart expand, so the right heart fills at the expense of the left heart - BP drops on inspiration.
Kussmaul sign - the neck veins (JVP, jugular venous pressure) RISE on inspiration instead of falling. Normally JVP falls on breathing in. In constrictive pericarditis, the fixed stiff shell can't accommodate the extra venous return, so pressure goes up.
Paradoxical increase in JVP on inspiration.
EDV (end-diastolic volume) decreases → Cardiac Output (CO) decreases → 1 venous return

Causes: TB (tuberculosis) is the most common cause worldwide (especially in resource-limited countries). Also: viral infections, cardiac surgery, radiation therapy.

On X-ray: Calcification of the pericardium is a clue.

PAGE 320 - KUSSMAUL SIGN, MYOCARDITIS, HEREDITARY HEMORRHAGIC TELANGIECTASIA, CARDIAC TUMORS, RHABDOMYOMAS

KUSSMAUL SIGN (detailed)

Normally when you breathe in, your chest creates negative (suction) pressure → blood flows from veins into the right heart → right heart fills up → JVP goes DOWN.
In constrictive pericarditis: the heart is trapped in a stiff shell. Blood tries to come in during inspiration but the shell can't expand → pressure backs up into the neck veins → JVP rises on inspiration (paradoxical, abnormal).
This is also called "paradoxical rise in JVP on inspiration."

MYOCARDITIS

"Myocarditis" = inflammation of the myocardium (the heart muscle itself).

Presentation: Can include:

Chest pain
Breathlessness
Fever
Tachycardia out of proportion to fever (heart beating much faster than the fever alone would explain) - this is a key clue.
Can lead to sudden cardiac death (SCD), especially in adults under 40.

Causes:

Viral (most common overall):

Parvovirus B19
Adenovirus
HIV, HHV-6, COVID-19
Coxsackievirus B - "highly indicative of viral myocarditis" with focal myocardial necrosis (areas of dead heart muscle)

Bacterial:

Borrelia burgdorferi (Lyme disease)
Corynebacterium diphtheriae (diphtheria toxin directly damages heart muscle)
Mycoplasma pneumoniae
Trypanosoma cruzi (Chagas disease - causes chronic cardiomyopathy, common in Latin America)

Autoimmune:

Kawasaki disease (affects coronary arteries in children)
Sarcoidosis, SLE, polymyositis/dermatomyositis

Drugs:

Doxorubicin (chemotherapy drug - can cause dilated cardiomyopathy)
Cocaine

Toxins:

Carbon monoxide
Black widow spider venom

Complications: Sudden death, arrhythmias, dilated cardiomyopathy (heart muscle weakens and enlarges like a stretched balloon), heart block, thrombus with systemic emboli.

HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT)

Also called Osler-Weber-Rendu syndrome.

Telangiectasia = abnormally dilated, fragile tiny blood vessels visible on skin/mucous membranes.
Hereditary = runs in families (autosomal dominant = you only need ONE copy of the bad gene from ONE parent to get the disease).

Signs:

Blanching lesions on skin (press on a red spot and it turns white - meaning it's a blood-filled vessel, not a bruise)
Epistaxis (nosebleeds) - very common, often the first sign
Tongue lesions
GI (gut) bleeding
GI and brain bleeding

Arteriovenous malformation (AVM) - this is a direct, abnormal shortcut connection between an artery and a vein, bypassing the capillaries. High-pressure blood goes directly into veins, which can rupture.

Most common complication: intracranial hemorrhage (bleeding in the brain) in children.

CARDIAC TUMORS

Myxomas (Most Common Cardiac Tumor in Adults)

A myxoma is a benign (non-cancerous) tumor made of gelatinous (jelly-like) material and myxoma cells immersed in glycosaminoglycans (a type of sugary protein matrix).
90% occur in the left atrium (the upper-left chamber of the heart), usually attached to the wall (called the "fossa ovalis" region).
Presents as a "ball valve" obstruction - the tumor swings back and forth, sometimes blocking the mitral valve.
Symptoms: Constitutional (fever, weight loss, fatigue), syncopal episodes (fainting), and a classic "tumor plop" sound heard with a stethoscope (a plopping sound as the tumor hits the valve).
IL-6 production by the tumor causes the constitutional symptoms (fever, fatigue).
Histology: Myxoma cells in a gelatinous matrix.

Rhabdomyomas (Most Common Cardiac Tumor in Children)

A benign tumor of cardiac muscle cells.
Most common in the ventricles (the lower pumping chambers).
Associated with tuberous sclerosis (a genetic condition causing benign tumors in multiple organs - brain, kidneys, skin, heart).
These are hamartomatous growths - meaning they are made up of normal tissue components but arranged abnormally (like a tissue "mistake" rather than a true tumor).

PAGE 321 - DEEP VEIN THROMBOSIS (DVT) & CARDIOVASCULAR PHARMACOLOGY (HYPERTENSION TREATMENT)

DEEP VEIN THROMBOSIS (DVT)

A DVT is a blood clot forming inside a deep vein - usually in the leg.

Signs: Redness, warmth, pain, swelling in the leg.

Virchow's Triad - the three conditions that predispose to clot formation:

Stasis (slow blood flow) - e.g., long car/plane journeys, post-op bed rest
Hypercoagulability (blood clots too easily) - e.g., Factor V Leiden mutation (a very common inherited clotting disorder), oral contraceptive use, pregnancy
Endothelial damage (injury to the vessel wall) - e.g., surgery, exposed collagen triggers clotting cascade

DVT of the proximal deep veins (iliac, femoral, popliteal) are the most dangerous because clots from these large veins can travel up to the lungs → Pulmonary Embolism (PE) - a life-threatening emergency.

Diagnosis:

D-dimer test - a blood test. It is very sensitive but NOT specific. A negative result helps RULE OUT DVT/PE in low-risk patients. If D-dimer is high and risk is moderate/high, you do imaging.
Compression ultrasound of the leg - the main imaging test.
Doppler - uses sound waves to check blood flow.

Treatment:

Unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH, e.g., enoxaparin) - injected blood thinners for initial treatment.
Anticoagulants for long-term: rivaroxaban, apixaban (oral blood thinners).

CARDIOVASCULAR PHARMACOLOGY - HYPERTENSION TREATMENT

"Hypertension" = persistently high blood pressure. The heart pumps blood through blood vessels, and if the vessels are too narrow or too stiff, the pressure rises - like water pressure in a pipe when you block it partially.

Primary (Essential) Hypertension (no single cause):

First-line treatment:

Thiazide diuretics (water pills - make kidneys excrete more salt and water)
ACE inhibitors (block a hormone called angiotensin II that constricts vessels)
ARBs (Angiotensin Receptor Blockers - block the receptor for angiotensin II)
Ca²+ channel blockers (block calcium entry into blood vessel muscle, causing relaxation)

Hypertension WITH Heart Failure:

ACE inhibitors/ARBs - reduce the workload on the failing heart
Beta-blockers (in compensated/stable HF) - slow the heart, reduce mortality
Aldosterone antagonists (e.g., spironolactone) - reduce fluid overload, improve mortality, reduce hospitalizations
Diuretics - remove excess fluid

Important rule: Beta-blockers are CONTRAINDICATED in decompensated HF (acutely worsening heart failure) and in cardiogenic shock (the heart is too weak - slowing it further is dangerous).

Hypertension WITH Diabetes:

ACE inhibitors/ARBs are PREFERRED - they protect the kidneys. Diabetes damages the kidney's filtering vessels → nephropathy. ACE inhibitors reduce pressure inside the kidney's tiny filters, slowing diabetic kidney damage.
Calcium channel blockers, thiazides, beta-blockers also used.
BUT: Beta-blockers can mask hypoglycemia symptoms (the shaking, sweating, palpitations of low blood sugar). So be careful.

Hypertension WITH Asthma:

ARBs, Ca²+ channel blockers, thiazide diuretics, cardioselective beta-blockers.
AVOID non-selective beta-blockers (like propranolol) - they block beta-2 receptors in the lungs, causing bronchoconstriction (airway tightening) = dangerous in asthma!
Also AVOID ACE inhibitors (they cause a dry cough which can worsen breathing and confuse asthma symptoms). The cough from ACE inhibitors is caused by buildup of bradykinin.

Hypertension IN PREGNANCY:

Hydralazine, methyldopa, labetalol, nifedipine - these are safe for the baby.
ACE inhibitors are CONTRAINDICATED in pregnancy (teratogenic - harm the fetus, especially kidneys).

Hypertension WITH GOUT:

Avoid loop and thiazide diuretics - they increase uric acid levels (cause hyperuricemia), triggering gout flares.
Use ACE inhibitors or ARBs (especially losartan - it actually lowers uric acid!).

Hypertension WITH OSTEOPOROSIS:

Thiazide diuretics are PREFERRED - they reduce calcium excretion in the urine (calcium-sparing), so they actually help maintain bone density.

Hypertension WITH PHEOCHROMOCYTOMA:

Pheochromocytoma = a tumor of the adrenal gland that secretes massive amounts of adrenaline (epinephrine/norepinephrine).
Treatment: Phenoxybenzamine (an alpha-blocker) FIRST, then add beta-blockers.
Why alpha first? The tumor releases lots of norepinephrine, which constricts blood vessels (alpha effect). If you give a beta-blocker first, you remove the beta-mediated vasodilation → blood vessels constrict even MORE → hypertensive crisis.
So always alpha-block first, then add beta-blockade if needed, before surgical removal.

PAGE 322 - ANTIANGINAL THERAPY & CARDIOVASCULAR MOLECULAR TARGETS DIAGRAM

ANTIANGINAL THERAPY

"Angina" = chest pain due to the heart muscle not getting enough blood (ischemia). Coronary arteries supply blood to the heart. When these are narrowed (atherosclerosis), increased demand leads to pain.

The goal: Reduce the heart's oxygen consumption (MVO₂ = myocardial oxygen consumption).

MVO₂ depends on: End-diastolic volume, BP, HR (heart rate), and contractility (how hard the heart squeezes).
Reduce any of these → less oxygen needed → no pain.

NITRATES (Nitroglycerin, Isosorbide dinitrate, Isosorbide mononitrate)

Mechanism:

Nitrates are converted in the body to Nitric Oxide (NO) - a gas molecule that signals blood vessel walls to relax.
NO → activates guanylate cyclase → increases cGMP (cyclic GMP) → smooth muscle relaxation.
This dilates veins mainly (reducing how much blood returns to the heart = reducing preload).
Also dilates arteries (reducing resistance = reducing afterload).
Result: Heart pumps against less resistance, and less blood fills it → less work → less oxygen demand → angina relieved.

Clinical use:

Angina, ACS (Acute Coronary Syndrome), acute pulmonary edema (fluid in lungs due to heart failure).

Adverse effects:

Reflex tachycardia (when BP drops, the body speeds up the heart to compensate).
Hypotension, flushing (skin redness), headache, dizziness.
"Monday disease" - in workers exposed to nitrates at work (factory workers), they develop tolerance over the work week. By the weekend (when not exposed), tolerance is lost. Monday back at work → headache, dizziness, tachycardia from re-exposure.

Important: Nitrates are CONTRAINDICATED with PDE-5 inhibitors (like sildenafil/Viagra). Both drugs lower blood pressure; together they cause a dangerous, potentially fatal drop in BP.

Also contraindicated in right ventricular infarction (the right side of the heart needs adequate filling pressure; nitrates reduce this).

THE CARDIOVASCULAR MOLECULAR TARGETS DIAGRAM (Page 322)

This complex diagram shows how various cardiovascular drugs work at the cellular level. Let me explain the key pathways:

Two main outcomes in blood vessel smooth muscle:

CONTRACTION (vessel narrows, BP rises)
RELAXATION (vessel dilates, BP falls)

Contraction pathway:

Calcium (Ca²+) enters the cell through L-type voltage-gated calcium channels.
Ca²+ binds calmodulin → activates MLC kinase (myosin light-chain kinase) → activates myosin → muscle contracts.
Rho kinase also promotes contraction by inhibiting the "off" switch.

Relaxation pathways:

cGMP pathway: Nitrates → NO → cGMP → activates PKG → inactivates MLC kinase → muscle relaxes.
cAMP pathway: Beta-agonists (like adrenaline on beta-2 receptors) → adenylate cyclase → cAMP → PKA → relaxation. Milrinone (PDE-3 inhibitor) increases cAMP by preventing its breakdown.
PDE-5 inhibitors (sildenafil): Stop the breakdown of cGMP → more cGMP → more relaxation → vessel dilation (used for pulmonary hypertension and erectile dysfunction).

Drugs on this diagram:

Calcium channel blockers (amlodipine, nifedipine, verapamil): Block the door through which calcium enters → less contraction.
Beta-2 agonists (Epi/NE on Gs receptor) → relax blood vessels.
Alpha-1 agonists (vasoconstriction).
ANP/BNP (natriuretic peptides - released by the heart when stretched) → bind natriuretic peptide receptor → cGMP → relaxation.

PAGE 323 - CALCIUM CHANNEL BLOCKERS

Calcium Channel Blockers

Drugs: Amlodipine, clevidipine, nicardipine, nifedipine, nimodipine, verapamil, diltiazem.

Mechanism: Block voltage-dependent L-type calcium channels.

On vascular smooth muscle (all CCBs): less calcium in → less contraction → blood vessels relax.
On heart (mainly verapamil and diltiazem): less calcium in → slower SA node (natural pacemaker) firing, slower AV node conduction, reduced contractility.

Two Main Groups:

1. Dihydropyridines (ending in "-dipine": nifedipine, amlodipine, nimodipine, nicardipine, clevidipine):

Primarily act on blood vessels (vascular smooth muscle).
Minimal direct heart effect at normal doses.
Good for hypertension, angina, Raynaud's phenomenon (fingers turning white/blue in cold due to vessel spasm).
Nimodipine - special: used for subarachnoid hemorrhage (bleeding around the brain) - prevents brain artery spasm.
Nicardipine, clevidipine - for hypertensive urgency/emergency (fast-acting IV forms).

2. Non-dihydropyridines (verapamil, diltiazem):

Act on BOTH heart AND blood vessels.
Slow the heart: useful for atrial arrhythmias (AFib/flutter rate control), angina, hypertension.
Verapamil has the strongest heart effect → bradycardia (slow heart), AV block (disrupted conduction between atria and ventricles), constipation (a notable side effect because it relaxes gut smooth muscle too!).
Diltiazem - between verapamil and nifedipine in terms of effect.

The hierarchy: Heart > Verapamil > Diltiazem > Amlodipine > Nifedipine > Clevidipine > Vascular smooth muscle

Side Effects of Dihydropyridines:

Gingival hyperplasia (gum overgrowth, especially with nifedipine)
Peripheral edema (ankles swelling)
Flushing (skin reddening)
Reflex tachycardia (fast heart rate as a reflex to BP drop)

Side Effects of Non-dihydropyridines (verapamil, diltiazem):

Cardiac depression (AV block, bradycardia)
Constipation (verapamil - major)

COMPARISON TABLE: Nitrates vs. Beta-Blockers vs. Nitrates + Beta-Blockers

Effect	Nitrates	Beta-Blockers	Together
End-diastolic volume	↓	↑	No net change
Blood pressure	↓	↓	↓↓
Contractility	↑ (reflex)	↓	Little/no effect
Heart rate	↑ (reflex)	↓	No effect or ↓

Why combine? Beta-blockers prevent the reflex tachycardia that nitrates cause. Nitrates prevent the rise in end-diastolic volume that beta-blockers can cause. They work synergistically for angina.

PAGE 324 - RANOLAZINE, SACUBITRIL, LIPID-LOWERING AGENTS

RANOLAZINE

Mechanism: Inhibits the late inward sodium current (a small, abnormal sodium channel current that persists when it shouldn't). This reduces intracellular sodium → reduces calcium overload in heart cells → reduces diastolic wall tension → less oxygen consumption.

Think of it as: it stops the heart from "leaking" sodium during late repolarization, which is wasteful and causes ischemia.

Clinical use: Refractory angina (angina that doesn't respond to other drugs).

Does NOT affect heart rate or blood pressure - this is what makes it unique!

Side effects: Constipation, dizziness, headache, nausea, QT prolongation (lengthens the heart's electrical recovery time - can predispose to arrhythmias).

SACUBITRIL

Mechanism: A neprilysin inhibitor.

What is neprilysin? It is an enzyme that breaks down natriuretic peptides (ANP, BNP) and bradykinin. When you inhibit neprilysin:

BNP/ANP levels rise → vasodilation → reduced preload and afterload → blood pressure falls, heart works less hard.
Also reduces ECF (extracellular fluid) volume.

Used as: Combined with valsartan (an ARB) - the combination drug is called Sacubitril/Valsartan (Entresto). Used to treat HFrEF (Heart Failure with reduced Ejection Fraction - when the heart is weak and can't pump properly).

Side effects:

Hypotension
Hyperkalemia (elevated potassium) - because it blocks the renin-angiotensin system
Angioedema (swelling of the face/throat) - the same risk as ACE inhibitors, because bradykinin builds up. This is why you CANNOT combine sacubitril with an ACE inhibitor!

LIPID-LOWERING AGENTS

Why lower lipids? High LDL cholesterol ("bad cholesterol") deposits in artery walls → plaques → narrowing → heart attacks and strokes.

STATINS (Atorvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin)

Mechanism: Inhibit HMG-CoA reductase - the key enzyme in the liver's cholesterol-making factory.

Less cholesterol made → liver makes more LDL receptors (like installing more "vacuum cleaners" on the liver to suck LDL out of the blood) → LDL goes down dramatically.
Also: Increase intrahepatic cholesterol recycling, increase LDL catabolism (breakdown).
Reduce mortality in patients with coronary artery disease (CAD) - this is the big reason we use them!

Effect on lipids: LDL ↓↓↓, HDL ↑ slightly, TG ↓ slightly.

Side effects:

Myopathy (muscle pain/weakness) - major concern. Risk increases if combined with fibrates or niacin.
Hepatotoxicity - liver enzyme elevation (monitor LFTs = liver function tests)
Gallstones - via inhibition of cholesterol 7α-hydroxylase (the enzyme that converts cholesterol to bile acids).

BILE ACID RESINS (Cholestyramine, Colesevelam, Colestipol)

Mechanism: These are large molecules that stay in the GUT and are not absorbed into the bloodstream.

They bind bile acids (made from cholesterol) in the intestine and prevent their reabsorption.
The liver has to make NEW bile acids from cholesterol → more cholesterol is used up → LDL receptor recycling increases → LDL goes down.

Effect: LDL ↓↓, HDL ↑ slightly, TG ↑ slightly (a downside).

Side effects: GI upset (bloating, constipation), decreased absorption of other drugs and fat-soluble vitamins (A, D, E, K) - take other medications separately!

EZETIMIBE

Mechanism: Prevents cholesterol absorption at the small intestine brush border (the inner surface of the small bowel where absorption happens).

Think of it as blocking the "door" through which dietary cholesterol enters the body.
Less cholesterol absorbed → liver compensates by upregulating LDL receptors → LDL in blood falls.

Effect: LDL ↓↓, HDL ↑/–, TG ↓/–.

Side effects: Rare - elevated LFTs (liver enzymes), diarrhea.

PAGE 325 - MORE LIPID-LOWERING AGENTS + DIAGRAM

FIBRATES (Fenofibrate, Gemfibrozil)

Mechanism: Activate PPAR-α (a nuclear receptor in cells that controls fat metabolism).

PPAR-α activation → upregulates LPL (lipoprotein lipase - the enzyme that breaks down triglycerides) → clears triglyceride-rich particles from blood.
Also increases HDL synthesis.

Effect: TG ↓↓↓ (the best drug for very high triglycerides!), HDL ↑↑, LDL ↓.

Side effects:

Myopathy (especially if combined with statins - increases risk of rhabdomyolysis = massive muscle breakdown!)
Cholelithiasis (gallstones)

NIACIN (Vitamin B3)

Mechanism: Activates PPAR-α → induces HDL synthesis. Also inhibits lipolysis (fat breakdown) in adipose (fat) tissue via hormone-sensitive lipase → less free fatty acids released → less VLDL made in liver → less LDL.

Effect: HDL ↑↑ (the best drug for raising HDL!), TG ↓, LDL ↓.

Side effects:

Flushing face (prostaglandin-mediated - can reduce by taking aspirin beforehand or with long-term use of niacin, the flushing diminishes; can reduce by NSAIDs)
Hyperglycemia (raises blood sugar)
Hyperuricemia (raises uric acid - can trigger gout)
Myalgias, GI upset
Delirium, dementia, neurocognitive effects (at high doses/long-term)

PCSK9 INHIBITORS (Alirocumab, Evolocumab)

Mechanism: PCSK9 is an enzyme that DESTROYS LDL receptors on liver cells.

Inhibiting PCSK9 → LDL receptors are NOT destroyed → more receptors on liver surface → more LDL pulled from bloodstream → LDL ↓↓↓ (dramatically, by 50-60%!).
These are injectable antibody drugs (monoclonal antibodies) given every 2-4 weeks.

Effect: LDL ↓ hugely, HDL ↑ slightly.

Used for: Familial hypercholesterolemia (a genetic condition with dangerously high cholesterol), patients who can't tolerate statins, or high-risk cardiovascular patients needing more LDL lowering.

FISH OIL AND OMEGA-3 FATTY ACIDS

Mechanism: Believed to increase LDL-receptor degradation → more LDL removed. Also increase FFA delivery to liver, reduce activity of TG-synthesizing enzymes, reduce VLDL production, and inhibit synthesis of ApoB (a protein needed to make VLDL particles).

Effect: TG ↓ (at high doses), HDL ↑ slightly, LDL ↑ slightly at high doses.

Side effects: Nausea, fishy taste.

THE LIPID METABOLISM DIAGRAM (Page 325)

This shows where each drug acts in the cholesterol cycle:

In the intestinal lumen: Ezetimibe blocks cholesterol absorption. Bile acid resins prevent bile acid reabsorption.
In the liver: Statins block HMG-CoA reductase (cholesterol synthesis). Niacin blocks VLDL secretion.
In the blood: Fibrates activate LPL → break down VLDL/TGs. PCSK9 inhibitors prevent LDL receptor destruction on liver cells.
Adipose tissue: Niacin inhibits lipolysis → less FFA → less substrate for VLDL.

Lipoproteins explained simply:

Chylomicrons (CHY) - carry dietary fat from gut through lymphatics to blood.
VLDL (Very Low Density Lipoprotein) - made in liver, carries triglycerides to tissues.
LDL (Low Density Lipoprotein) - "bad" cholesterol. Deposits in artery walls.
HDL (High Density Lipoprotein) - "good" cholesterol. Takes cholesterol FROM arteries BACK to liver.
FFA = Free Fatty Acids (fuel molecules in the blood).

PAGE 326 - DIGOXIN & ANTIARRHYTHMICS CLASS I (SODIUM CHANNEL BLOCKERS)

DIGOXIN

Origin: From the foxglove plant. One of the oldest heart medications.

Mechanism:

Directly inhibits Na⁺/K⁺-ATPase pump - This pump normally pushes sodium OUT and potassium IN. When it's inhibited:
- Sodium builds up inside the heart cell.
- The Na⁺/Ca²+ exchanger (which uses the sodium gradient to push calcium OUT) can no longer work effectively.
- Calcium accumulates inside the heart cell.
- More calcium = stronger heart contractions (positive inotropy = increased contractility).
Stimulates vagus nerve → slows AV node conduction → decreases heart rate.

Clinical Use:

Heart Failure: Increases contractility (makes the weak heart pump harder).
Atrial fibrillation (AFib): Slows ventricular rate by blocking the AV node.

Digoxin Toxicity:

Cholinergic effects: Nausea, vomiting, diarrhea, blurry yellow-green vision (classic - patients see a yellow/green halo) - Van Gogh allegedly had digoxin toxicity from foxglove and painted everything yellow.
Arrhythmias: Can cause atrial tachycardia with AV block, ventricular arrhythmias.
Hyperkalemia (high potassium) - because NaKATPase is blocked, K⁺ can't get into cells.

Factors making toxicity more likely (predisposing):

Renal failure (↑ digoxin excretion problems)
Hypokalemia (↓ potassium) - interestingly, LOW potassium WORSENS digoxin toxicity because potassium and digoxin compete for the same binding site on NaKATPase.
Drugs binding at K⁺-binding site on NaKATPase: verapamil, amiodarone, quinidine.

Antidote: Anti-digoxin Fab fragments (antibody fragments that bind digoxin directly). Also: correct K⁺, Mg²+, normalize K⁺-binding site.

ANTIARRHYTHMICS - CLASS I: SODIUM CHANNEL BLOCKERS

The heart's electrical conduction: The heart generates its own electrical impulses. For the heart to beat regularly, these electrical signals must travel through specific pathways in a coordinated way. Sodium channels are responsible for the rapid electrical charge that spreads across heart cells (Phase 0 depolarization).

Class I drugs - block sodium channels → slow conduction through heart tissue.

CLASS IA: Quinidine, Procainamide, Disopyramide ("The green proclaims Diso's pyramid")

Mechanism:

Slow or block conduction (especially in depolarized cells, i.e., cells that are currently "fired up").
State dependent - bind more to open sodium channels.
↑ HR (faster heart rate as a reflex)
Shorter diastole → Na⁺ channels spend less time in resting state → less time for drug to dissociate from the channel.
Prolong refractory period (RP) - the time during which cells can't fire again.
↑ AP duration (action potential duration - the length of the electrical event).
↑ QT interval (a measure on the ECG of the time the heart takes to reset electrically) - can cause dangerous arrhythmia (Torsades de pointes = a life-threatening abnormal heart rhythm).

Class IA effect is most pronounced in IC > IB due to relative binding strength. Fast taxi CAB (mnemonic: Class IC binds most strongly, then IA, then IB - so IC > IA > IB for binding strength).

Clinical Use: Both atrial and ventricular arrhythmias, especially reentrant SVT (Supraventricular tachycardia - fast heart rate from the upper chambers) and VT (Ventricular tachycardia).

Adverse effects:

Quinidine: Cinchonism (headache, tinnitus = ringing in ears, dizziness), reversible SLE-like syndrome (looks like lupus), thrombocytopenia, Torsades de pointes, ↑ QT.
Procainamide: Reversible SLE-like syndrome (very common - lupus drug!), agranulocytosis (loss of white blood cells).
Disopyramide: Anticholinergic effects.

CLASS IB: Lidocaine, Mexiletine ("To Buy Liddy's Mexican tacos")

Mechanism:

Weak Na⁺ channel blockade.
↑ AP (action potential) duration → prolonged repolarization time.
Preferentially affect ischemic or depolarized Purkinje and ventricular tissue (e.g., tissue injured by a heart attack) - they preferentially work where the problem is!
↑ slope of phase 4 depolarization - meaning normal pacemaker cells can still generate impulses (minimal effect on normal tissue).

Clinical Use:

Acute ventricular arrhythmias (especially post-MI - after a heart attack).
Digitalis-induced arrhythmias.
IB is best post-MI.
Lidocaine - also famous as a local anesthetic (numbs tissue).

Side Effects:

CNS effects: sedation, sleep changes, CNS stimulation (seizures at toxic doses), cardiovascular depression.

PAGE 327 - CLASS IC AND CLASS II ANTIARRHYTHMICS

CLASS IC: Flecainide, Propafenone ("Can I have fries, please?")

Mechanism:

Strong Na⁺ channel blockade.
Significantly prolongs ERP (Effective Refractory Period) in AV node, accessory bypass tracts, Purkinje, and ventricular tissue.
Minimal effect on AP duration (unlike IA and IB).

Clinical Use:

SVTs (Supraventricular Tachycardias), including atrial fibrillation.
Refractory VT (ventricular tachycardia that won't respond to other drugs) - only as a last resort.
Proarrhythmic - especially post-MI (can make arrhythmias worse!).
IC is CONTRAINDICATED in structural and ischemic heart disease - if the heart is already damaged (e.g., after a heart attack), flecainide can cause lethal arrhythmias.

The CAST trial showed that using IC drugs after MI increased deaths, despite suppressing arrhythmias on ECG.

CLASS II ANTIARRHYTHMICS - BETA-BLOCKERS

Drugs: Metoprolol, propranolol, esmolol, atenolol, timolol, carvedilol.

Mechanism:

Decrease SA node (sinus node = the heart's natural pacemaker) and AV node activity by ↓ cAMP (reducing the signal that speeds up the heart) and ↓ Ca²+ currents.
↓ slope of phase 4 - the pacemaker potential fires less steeply → slower heart rate.
Suppresses abnormal pacemakers by reducing automaticity.

Clinical Use:

AV node rate control for atrial fibrillation and atrial flutter.
Prevent ventricular arrhythmias.
Specifically post-MI (after a heart attack, beta-blockers reduce risk of sudden death).

Side Effects (very important):

Bradycardia (slow heart rate), AV block, worsening of HF if decompensated.
Impotence (erectile dysfunction).
Exacerbation of COPD and asthma (beta-2 blockade narrows airways).
CNS effects: Sedation, sleep alterations, depression (lipophilic ones like propranolol cross into brain more).
Mask hypoglycemia symptoms (the sympathetic signs of low blood sugar: palpitations, sweating are masked, but NOT diaphoresis/sweating).
Dyslipidemia (can increase triglycerides, lower HDL).

Special notes:

Esmolol = very short-acting (minutes). Good for acute situations where you need quick heart rate control.
Metoprolol = cardioselective (β₁-selective) - acts mainly on heart, less on lungs. Safer in mild asthma.
Propranolol = non-selective (β₁ and β₂) - blocks both heart and lungs.
Carvedilol = blocks α₁, β₁, and β₂ (triple blockade) - also causes vasodilation.
Labetalol = blocks α and β - useful in pregnancy hypertension.

Beta-blockers can WORSEN vasospastic angina (Prinzmetal's/variant angina) because beta-blockade leaves alpha receptors unopposed → coronary artery spasm.

β-blocker overdose: Treat with Glucagon (raises cAMP, bypassing beta-receptors), Atropine, Saline (CAS mnemonic).

The pacemaker cell action potential diagram (bottom right of page 327): Shows how the threshold potential is reached during phase 4 (spontaneous depolarization) and how beta-blockers flatten this slope → slower pacing → slower heart rate.

SUMMARY - The Big Picture

Topic	Key Point
Syncope	Transient loss of consciousness; reflex = most common
Infective Endocarditis	Bacteria on heart valves; Acute = S. aureus (destroys normal valves); Subacute = S. viridans (damaged valves)
NBTE	Sterile clots on valves; associated with cancer/lupus
Rheumatic Fever	Post-strep; molecular mimicry damages heart valves; Aschoff bodies
Syphilitic Heart Disease	Tertiary syphilis → "tree bark" aorta
Pericarditis	Chest pain better leaning forward; friction rub; treat with NSAIDs + colchicine
Myocarditis	Viral most common; Coxsackievirus B
Cardiac Tumors	Myxoma = most common adult (left atrium); Rhabdomyoma = children (tuberous sclerosis)
Nitrates	Vasodilate veins > arteries; reduce preload; treat angina
CCBs	Dihydropyridines = vessels; Non-DHP (verapamil, diltiazem) = heart + vessels
Statins	Block HMG-CoA reductase; most powerful LDL lowering
Digoxin	Na-K-ATPase inhibitor; + inotropy; slows AV node
Class IA	Quinidine, Procainamide; ↑QT; lupus risk (procainamide)
Class IB	Lidocaine; best post-MI; works on ischemic tissue
Class IC	Flecainide; strongest Na blockade; CONTRAINDICATED post-MI
Class II	Beta-blockers; slow SA/AV node

This covers every line from all 10 pages of your cardiology notes. Each drug, each mechanism, each disease has been explained from first principles so even someone with no medical background can follow the logic. Let me know if you want any section expanded further!

This is a shared conversation. Sign in to Orris to start your own chat.